Supported by advanced structural biology capabilities at MAX IV, Acrivon Therapeutics advanced a novel cancer drug candidate from initial lead identification to clinical development in only 15 months.
X-ray study gives clues to earlier osteoarthritis detection
Osteoarthritis is a painful, sometimes disabling and irreversible condition that affects many people. A recent study by researchers from Lund, Sweden and Switzerland confirms that X-ray imaging is an important tool for developing indicators that could aid early detection to slow progression.
Unique biomaterial found in a lizard
Researchers have found a biomaterial with surprising features in the skin of a lizard. The material is hard like enamel but is structured differently. Understanding the material on the nanoscale opens up new routes in designing for hard-wearing applications.
Tribute to Alexei Zakharov
It is with great sadness that we inform that Alexei Zakharov, beamline scientist at the MAXPEEM beamline, passed away on 10 July 2025. Alex was an excellent scientist, enthusiastic researcher, great colleague and friend. Internationally renowned, Alex personified PEEM at the MAX IV Laboratory, both for the staff and for our users. After studying physics
Preparing for a new user landscape with LEAPS-INNOV-funded workshop
Inviting new user groups and moving towards more complex and diverse samples require synchrotron facilities to challenge their ways of operation. An important step was taken when beamline scientists and users met to discuss and solve issues in a recent workshop.
International collaboration advances research in two-dimensional gold nanostructures
An international team of researchers from Hokkaido University, Lund University, MAX IV Laboratory in Sweden, and Diamond Light Source in the UK has made significant progress in synthesising nanostructured two-dimensional gold films. This development could pave the way for advances in catalysis, electronics, and energy conversion.
Long-term governmental funding of MAX IV enabled by a change in ordinance
Today, the Swedish Government announces a modification of the ordinance that governs funding granted to research infrastructure of national interest. The change in the governing documents will allow the Swedish Research Council to grant funding for up to 10 years for MAX IV and similar research infrastructure.
Protection for large intestine and migraine medication – news from MAX IV users
Gel baserad på matavfall kan skydda tjocktarmen I global livsmedelsproduktion går en tredjedel av den råvara som används till spillo varje år. Forskare vid KTH har funnit ett nytt användningsområde för den del av maten som annars skulle gå förlorad. Uppfinningen är en gel baserad på majsfibrer som bland annat skulle kunna ingå i mat
Robert Feidenhans’l is the new chair of the MAX IV board
Lund University has appointed Robert Feidenhans’l as chair of the board for the MAX IV research facility in Lund. The term of office runs from 1 January 2023 to 31 December 2025. “Robert Feidenhans’l is a fantastic asset for MAX IV and for Sweden’s work on research infrastructures. He is an internationally leading authority within
Exploring the structure of industrial polymers with the help of the CoSAXS beamline
People consume goods daily without realising the journey those products have been through before being displayed on store shelves. Everything involved in the production is a result of thorough R&D, even the eye-catching package of the products has gone through a substantial evolution. To this day, researchers are working on taking the packaging to the